July 30, 2018
1153 Recent Articles
July 30, 2018
Tribal Immunity Does Not Save Allergan’s Patents from IPR
July 30, 2018
Be Careful What You Wish For: Broad Claim Construction Sought by Patent Owner Results in Invalidity for Lack of Enablement
July 30, 2018
What’s Zup? Water Board Patent Obvious; Secondary Considerations Too Weak to Show Otherwise
July 30, 2018
Distribution of Catalogs at a Tradeshow Was Accessible with Reasonable Diligence, and was a Printed Publication Under 102(b)
July 30, 2018
Materials Available Online, Identified in Federal Register Before the Critical Date Were Printed Publications
July 30, 2018
Federal Circuit: Expensive Attorneys Are Not “Expenses” Under Section 145
July 26, 2018
BioPharma Patents Quick Tips & News – May 2015 – Throwback Edition
July 24, 2018
Bad Vibes in Kim Kardashian West Trademark Row
July 13, 2018
Unreasonably Broad Construction Unlimited by the Specification, Resulted in Incorrect Finding of Anticipation
July 13, 2018
Federal Circuit Finds No Error in District Court Determination the Claimed Invention was not Obvious
July 12, 2018
BioPharma Patents Quick Tips & News – March 2015 – Throwback Edition
July 11, 2018
Section 101: The Facts, the Whole Facts and Nothing but the Facts
July 06, 2018
A Chicken in Every Pot, A Patent in Every Portfolio
July 06, 2018
No-Harm, No-Foul: Board Denies Sanctions Where Patent Owner Suffered No Harm from Alleged Cross Examination Overreach
July 05, 2018
Third Time’s The Charm: Federal Circuit Remands for Third Damages Trial Because Patent Owner Did Not Prove Use of Entire Market Value was Appropriate
July 05, 2018
Concrete Allegations that Claim Elements are Not Well-Understood, Routine, or Conventional Prevents Dismissal under Rule 12(b)(6)
July 05, 2018
TTAB Scores a ZERO in Evaluating Genericness and Acquired Distinctiveness
July 04, 2018
Have a Happy and Safe Fourth of July
July 03, 2018